Need professional-grade analysis? Visit stockanalysis.com
$147.99M
N/A
13
N/A
Immunovia publ AB (IMMNOV) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at SEK0.20, up 1.00% from the previous close.
Over the past year, IMMNOV has traded between a low of SEK0.16 and a high of SEK0.75. The stock has lost 2.3% over this period. It is currently 72.9% below its 52-week high.
Immunovia publ AB has a market capitalization of $147.99M.
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Side-by-side comparison against top Healthcare peers.